Bernstein trims AstraZeneca target to 198 pounds
Bernstein cut its price target on AstraZeneca to 198 pounds from 200 pounds and kept a positive view on the drugmaker's long-term outlook. Shares in AstraZeneca were up 1% at 120.80 pounds.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bernstein cut its price target on AstraZeneca to 198 pounds from 200 pounds and kept a positive view on the drugmaker's long-term outlook. Shares in AstraZeneca were up 1% at 120.80 pounds.
Bernstein cut its target price on AstraZeneca to 198 pounds from 200 pounds and kept a positive view on the drugmaker’s pipeline. Shares were up 1% at 120.80 pounds.
Bernstein said AstraZeneca’s research engine remains intact despite recent setbacks and trimmed its target price to 198 pounds from 200 pounds.